Here’s a brief look at 6 medications for rheumatologic disorders that were newly approved in the second half of 2018.
Number of Rheumatologists Increased More Than 20% Over Last Decade
Emerging Agents in the Treatment of Rheumatic Diseases
Thiocyanate Exposure Linked to Greater Arthritis Risk, Heightened Inflammation Indicators
Challenges with Step Therapy Protocols in Treating Rheumatoid Arthritis
Pegloticase, Methotrexate Co-Therapy Has Similar Safety, Efficacy for Uncontrolled Gout Regardless of CKD Status
Bodyweight Exercises Improve Strength, Patient-Reported Outcomes in Female Patients with RA